Aspira Womens Health Stock Analysis

AWH Stock  USD 0.81  0.05  6.58%   
Aspira Womens Health is undervalued with Real Value of 1.78 and Target Price of 4.8. The main objective of Aspira Womens stock analysis is to determine its intrinsic value, which is an estimate of what Aspira Womens Health is worth, separate from its market price. There are two main types of Aspira Womens' stock analysis: fundamental analysis and technical analysis.
The Aspira Womens stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aspira Womens' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Aspira Stock Analysis Notes

About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.15. Aspira Womens Health last dividend was issued on the 16th of December 2016. The entity had 1:15 split on the 12th of May 2023. Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people. For more info on Aspira Womens Health please contact Nicole CPA at 512 519 0400 or go to https://aspirawh.com.

Aspira Womens Quarterly Total Revenue

2.26 Million

Aspira Womens Health Investment Alerts

Aspira Womens Health generated a negative expected return over the last 90 days
Aspira Womens Health has some characteristics of a very speculative penny stock
Aspira Womens Health has high historical volatility and very poor performance
The company reported the last year's revenue of 9.15 M. Reported Net Loss for the year was (16.69 M) with profit before taxes, overhead, and interest of 4.32 M.
Aspira Womens Health has about 20.48 M in cash with (15.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Aspira Womens Health has a poor financial position based on the latest SEC disclosures
Roughly 31.0% of the company shares are held by company insiders
Latest headline from gurufocus.com: Aspira Womens Health Inc Q3 2024 Earnings Call Highlights Strategic Wins Amidst Market ...

Aspira Womens Health Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aspira Womens previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Aspira Largest EPS Surprises

Earnings surprises can significantly impact Aspira Womens' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-11-08
2018-09-30-0.03-0.04-0.0133 
2018-05-14
2018-03-31-0.04-0.05-0.0125 
2018-03-13
2017-12-31-0.04-0.05-0.0125 
View All Earnings Estimates

Aspira Stock Institutional Investors

Shares
M&t Bank Corp2024-06-30
15 K
Two Sigma Securities, Llc2024-06-30
13.5 K
Squarepoint Ops Llc2024-06-30
12.3 K
Hrt Financial Llc2024-06-30
10.9 K
Tower Research Capital Llc2024-06-30
6.7 K
Morgan Stanley - Brokerage Accounts2024-06-30
4.8 K
Royal Bank Of Canada2024-06-30
2.3 K
Advisor Group Holdings, Inc.2024-06-30
2.3 K
Jpmorgan Chase & Co2024-06-30
2.1 K
Armistice Capital, Llc2024-09-30
1.3 M
Vanguard Group Inc2024-09-30
274.1 K
Note, although Aspira Womens' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aspira Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 13.5 M.

Aspira Profitablity

The company has Net Profit Margin of (1.79) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (1.81) %, which entails that for every $100 of revenue, it lost $1.81.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.67)(2.53)
Return On Capital Employed(16.49)(15.67)
Return On Assets(2.67)(2.53)
Return On Equity 7.06  7.41 

Management Efficiency

Aspira Womens Health has Return on Asset of (1.8571) % which means that on every $100 spent on assets, it lost $1.8571. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (7.2345) %, meaning that it generated no profit with money invested by stockholders. Aspira Womens' management efficiency ratios could be used to measure how well Aspira Womens manages its routine affairs as well as how well it operates its assets and liabilities. The Aspira Womens' current Return On Equity is estimated to increase to 7.41, while Return On Tangible Assets are forecasted to increase to (2.53). As of now, Aspira Womens' Fixed Asset Turnover is increasing as compared to previous years. The Aspira Womens' current Asset Turnover is estimated to increase to 1.53, while Total Assets are projected to decrease to under 5.9 M.
Last ReportedProjected for Next Year
Book Value Per Share(0.26)(0.24)
Tangible Book Value Per Share(0.26)(0.24)
Enterprise Value Over EBITDA(2.30)(2.41)
Price Book Value Ratio(15.93)(15.13)
Enterprise Value Multiple(2.30)(2.41)
Price Fair Value(15.93)(15.13)
Enterprise Value34.1 M32.4 M
Effective management at Aspira Womens has been a driving force behind its market achievements. We assess the correlation between management practices and financial success to determine the stock's value.
Operating Margin
(1.81)
Profit Margin
(1.79)
Beta
1.438
Return On Assets
(1.86)
Return On Equity
(7.23)

Technical Drivers

As of the 29th of November, Aspira Womens shows the Risk Adjusted Performance of (0.03), standard deviation of 4.89, and Mean Deviation of 3.02. Aspira Womens Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aspira Womens Health Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aspira Womens middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aspira Womens Health. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Aspira Womens Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aspira Womens insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aspira Womens' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aspira Womens insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aspira Womens Outstanding Bonds

Aspira Womens issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aspira Womens Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aspira bonds can be classified according to their maturity, which is the date when Aspira Womens Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Aspira Womens Predictive Daily Indicators

Aspira Womens intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aspira Womens stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aspira Womens Forecast Models

Aspira Womens' time-series forecasting models are one of many Aspira Womens' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aspira Womens' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Aspira Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aspira Womens prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aspira shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aspira Womens. By using and applying Aspira Stock analysis, traders can create a robust methodology for identifying Aspira entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(1.82)(1.91)
Operating Profit Margin(2.06)(2.16)
Net Loss(1.82)(1.91)
Gross Profit Margin 0.57  0.63 

Current Aspira Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aspira analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aspira analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.8Buy3Odds
Aspira Womens Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Aspira analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aspira stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aspira Womens Health, talking to its executives and customers, or listening to Aspira conference calls.
Aspira Analyst Advice Details

Aspira Stock Analysis Indicators

Aspira Womens Health stock analysis indicators help investors evaluate how Aspira Womens stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aspira Womens shares will generate the highest return on investment. By understating and applying Aspira Womens stock analysis, traders can identify Aspira Womens position entry and exit signals to maximize returns.
Begin Period Cash Flow13.6 M
Common Stock Shares Outstanding9.2 M
Total Stockholder Equity-2.4 M
Property Plant And Equipment Net693 K
Cash And Short Term Investments2.6 M
Cash2.6 M
Accounts Payable1.3 M
Net Debt255 K
50 Day M A0.8344
Total Current Liabilities5.1 M
Other Operating Expenses28 M
Non Current Assets Total982 K
Non Currrent Assets Other289 K
Stock Based Compensation1.7 M

Complementary Tools for Aspira Stock analysis

When running Aspira Womens' price analysis, check to measure Aspira Womens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womens is operating at the current time. Most of Aspira Womens' value examination focuses on studying past and present price action to predict the probability of Aspira Womens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspira Womens' price. Additionally, you may evaluate how the addition of Aspira Womens to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum